Tag Archives: oncology

We’re always on the lookout for biotech runners, and one that’s impossible to overlook right now is Transgenomic Inc (NASDAQ:TBIO). The company gained close to 300% on Thursday, and looks set to continue its run into the end of...

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) is one of the week’s biggest biotech runners, up close to 200% on the Monday open. At a glance, there doesn’t look to be too much we can pin the gains on – there has been no news...

Biocept Inc (NASDAQ:BIOC) gained more than 77% during Tuesday’s session this week, and is up more than 100% on last week’s close, on news that the company has picked up a fresh round of insurance coverage for its lead biopsy product....

At the end of first quarter 2014, Immune Pharmaceuticals Inc (NASDAQ:IMNP) traded for just shy of $4.50 a share. During the 36 or so months since, the company has declined to trade at current levels below $0.2 a share – a more than 95% decline...

Pharmacyte Biotech Inc (OTCMKTS:PMCB) just put out a press release detailing some research conducted in Chicago, and the company has picked up an 11% boost on the release. The research doesn’t relate directly to PharmaCyte, but it does...

Propanc Health Group Corp (OTCMKTS:PPCH) is a junior biotech company that currently has two separate orphan designation applications with the European Medicines Agency (EMA) for its lead asset, PRP. One of the applications should feed back...

Interpace Diagnostics Group Inc (NASDAQ:IDXG) is a mid December runner, gaining strength on the news that the company’s thyroid cancer testing tech will now be covered by Aetna Inc (NYSE:AET). The coverage adds millions of new potential...

Pharmacyte Biotech Inc (OTCMKTS:PMCB) is moving on high volume. The company is up 70% on its weekly open, and the gains come as Pharmactye edges towards enrolment in its pancreatic cancer trial. It’s been one of most watched companies...

Immune Pharmaceuticals Inc (NASDAQ:IMNP) is a big runner this week, up more than 55% on its Monday open. The company announced back on November 22 that it will host an R&D update event on December 8, and it looks as though someone is loading...

Q BioMed Inc (OTCMKTS:QBIO) was one of our focus biotech stocks back at the end of September, when the company started to run up on positive news. We highlighted it as being one to watch, and recent action has vindicated out highlighting. The...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter